Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy

Anti-PD-1 therapy has demonstrated significant activity in metastatic melanoma. We report good local control and minimal neurotoxicity with the combination of nivolumab and stereotactic radiation in the management of melanoma brain metastases. Overall survival and distant brain metastases control appear improved.

from Cancer via ola Kala on Inoreader http://ift.tt/1S881zA
via IFTTT